Overview
- 20 inspections across 19 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-05-02.
At a glance
Inspections
20
Sites
19
Observations
0
Career since
Apr 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Precigen Inc | 2 May 2025 | Biologics | |
| Pierre Fabre Pharmaceuticals, Inc. | 30 Oct 2024 | Biologics | |
| Atara Biotherapeutics, Inc. | 30 Oct 2024 | Biologics | |
| Kedrion S.p.A. | 28 Aug 2024 | Biologics | |
| Laboratorios Farmacuticos Rovi, S.A. | 24 Jan 2024 | Biologics |
Sites inspected
Precigen IncGermantown, United States1 insp.
Pierre Fabre Pharmaceuticals, Inc.Aurora, United States1 insp.
Atara Biotherapeutics, Inc.Aurora, United States1 insp.
Kedrion S.p.A.Gallicano, Italy1 insp.
Laboratorios Farmacuticos Rovi, S.A.Granada, Spain1 insp.
Co-investigators
Investigators who share inspections with this person.
Susan M Jackson4 shared
Erin C Hill3 shared
Grace I Cortesini2 shared
Ou Ma2 shared
Holly Brevig2 shared
Christine Harman2 shared
Darcel T Bigelow2 shared
Priscilla M Pastrana2 shared
Meihong Liu2 shared
Teresita C Mercado2 shared
Full investigator report
Get the verbatim findings behind Hector A Carrero's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site